Brian Lian is President & CEO of Viking Therapeutics, Inc.. Currently has a direct ownership of 2.14 Million shares of VKTX, which is worth approximately $182 Million. The most recent transaction as insider was on Feb 09, 2024, when has been sold 45,000 shares (Common stock, par value $0.00001 per share) at a price of $29.9 per share, resulting in proceeds of $1,345,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.14M
2.64% 3M change
5.85% 12M change
Total Value Held $182 Million

Brian Lian Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 09 2024
SELL
Open market or private sale
$1,345,500 $29.9 p/Share
45,000 Reduced 2.06%
2,139,882 Common stock, par valu...
Feb 08 2024
SELL
Open market or private sale
$7,265,133 $27.0 p/Share
269,079 Reduced 10.97%
2,184,882 Common stock, par valu...
Feb 08 2024
BUY
Exercise of conversion of derivative security
$555,892 $2.94 p/Share
189,079 Added 7.29%
2,404,882 Common stock, par valu...
Jan 31 2024
SELL
Open market or private sale
$2,099,500 $24.7 p/Share
85,000 Reduced 3.62%
2,264,882 Common stock, par valu...
Jan 31 2024
BUY
Exercise of conversion of derivative security
$104,550 $1.23 p/Share
85,000 Added 3.49%
2,349,882 Common stock, par valu...
Jan 30 2024
SELL
Open market or private sale
$838,250 $23.95 p/Share
35,000 Reduced 1.52%
2,264,882 Common stock, par valu...
Jan 30 2024
BUY
Exercise of conversion of derivative security
$43,050 $1.23 p/Share
35,000 Added 1.5%
2,299,882 Common stock, par valu...
Jan 04 2024
SELL
Payment of exercise price or tax liability
$734,876 $18.58 p/Share
39,552 Reduced 1.72%
2,264,882 Common stock, par valu...
Jan 03 2024
SELL
Payment of exercise price or tax liability
$3,734,735 $17.4 p/Share
214,640 Reduced 8.52%
2,304,434 Common stock, par valu...
Jan 03 2024
BUY
Grant, award, or other acquisition
-
310,000 Added 11.39%
2,410,549 Common stock, par valu...
May 01 2023
SELL
Open market or private sale
$1,010,250 $22.45 p/Share
45,000 Reduced 2.01%
2,197,963 Common stock, par valu...
Apr 19 2023
SELL
Open market or private sale
$750,750 $21.45 p/Share
35,000 Reduced 1.54%
2,242,963 Common stock, par valu...
Apr 17 2023
SELL
Open market or private sale
$3,169,750 $20.45 p/Share
155,000 Reduced 6.37%
2,277,963 Common stock, par valu...
Apr 17 2023
BUY
Exercise of conversion of derivative security
$268,750 $2.15 p/Share
125,000 Added 4.89%
2,432,963 Common stock, par valu...
Apr 13 2023
SELL
Open market or private sale
$1,463,749 $18.45 p/Share
79,336 Reduced 3.32%
2,307,963 Common stock, par valu...
Apr 13 2023
BUY
Exercise of conversion of derivative security
$102,151 $1.88 p/Share
54,336 Added 2.23%
2,387,299 Common stock, par valu...
Apr 03 2023
SELL
Payment of exercise price or tax liability
$3,514,000 $17.57 p/Share
200,000 Reduced 7.9%
2,332,963 Common stock, par valu...
Apr 03 2023
SELL
Open market or private sale
$392,700 $17.85 p/Share
22,000 Reduced 0.98%
2,232,963 Common stock, par valu...
Apr 03 2023
BUY
Grant, award, or other acquisition
-
300,000 Added 10.59%
2,532,963 Common stock, par valu...
Mar 31 2023
SELL
Open market or private sale
$1,186,076 $17.45 p/Share
67,970 Reduced 2.93%
2,254,963 Common stock, par valu...
Mar 31 2023
BUY
Exercise of conversion of derivative security
$645,035 $9.49 p/Share
67,970 Added 2.84%
2,322,933 Common stock, par valu...
Mar 30 2023
SELL
Open market or private sale
$2,638,170 $17.2 p/Share
153,382 Reduced 6.37%
2,254,963 Common stock, par valu...
Mar 30 2023
BUY
Exercise of conversion of derivative security
$725,647 $5.36 p/Share
135,382 Added 5.32%
2,408,345 Common stock, par valu...
Jan 04 2023
SELL
Payment of exercise price or tax liability
$240,971 $8.42 p/Share
28,619 Reduced 1.24%
2,272,963 Common stock, par valu...
Jan 03 2023
SELL
Payment of exercise price or tax liability
$581,507 $8.52 p/Share
68,252 Reduced 2.88%
2,301,582 Common stock, par valu...
Monitor Stock Transactions by Investors and Insiders for Free!

Stay Ahead of the Market by Anticipating Purchase and Sale Activities with Early Access, Take Control of Your Trading and Investment Opportunities - Sign Up Now.

Also insider at

SEEL
SEELOS THERAPEUTICS, INC. Healthcare
BL

Brian Lian

President & CEO
San Diego, CA

Track Institutional and Insider Activities on VKTX

Follow Viking Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VKTX shares.

Notify only if

Insider Trading

Get notified when an Viking Therapeutics, Inc. insider buys or sells VKTX shares.

Notify only if

News

Receive news related to Viking Therapeutics, Inc.

Track Activities on VKTX